Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane van der Vliet

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
La Revue Du Praticien|May 30, 2006
[Vaccinations]Diane van der Vliet, Odile Launay
Plos Neglected Tropical Diseases|July 15, 2016
Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical TrialsSophia Gailhardou, Anna Skipetrova, Gustavo H Dayan, et al.
Human Vaccines|October 12, 2010
Similar immunogenicity of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccineDiane Van der Vliet, Stephanie Pepin, Michel Lambert, et al.
The American Journal of Tropical Medicine and Hygiene|August 10, 2006
Pseudomonas aeruginosa otochondritis complicating localized cutaneous leishmaniasis: prevention of mutilation by early antibiotic therapyDiane Van Der Vliet, Anne-Sophie Le Guern, Sylvie Freitag, et al.
The Journal of Infectious Diseases|October 3, 2017
Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus SheddingJoseph Torresi, Peter C Richmond, Leon G Heron, et al.
JAMA|April 14, 2011
Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trialOdile Launay, Diane van der Vliet, Arielle R Rosenberg, et al.
Vaccine|August 18, 2015
Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: a randomised studyJoseph Torresi, Leon G Heron, Ming Qiao, et al.
Arthritis Care & Research|April 5, 2013
Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort studySolen Kernéis, Odile Launay, Thierry Ancelle, et al.
Elife|September 6, 2017
Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacyMaia A Rabaa, Yves Girerd-Chambaz, Kien Duong Thi Hue, et al.
Vaccine|January 13, 2009
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trialOdile Launay, Christine Sadorge, Nathalie Jolly, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|May 30, 2006
[Vaccinations]Diane van der Vliet, Odile Launay
Plos Neglected Tropical Diseases|July 15, 2016
Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical TrialsSophia Gailhardou, Anna Skipetrova, Gustavo H Dayan, et al.
Human Vaccines|October 12, 2010
Similar immunogenicity of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccineDiane Van der Vliet, Stephanie Pepin, Michel Lambert, et al.
The American Journal of Tropical Medicine and Hygiene|August 10, 2006
Pseudomonas aeruginosa otochondritis complicating localized cutaneous leishmaniasis: prevention of mutilation by early antibiotic therapyDiane Van Der Vliet, Anne-Sophie Le Guern, Sylvie Freitag, et al.
The Journal of Infectious Diseases|October 3, 2017
Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus SheddingJoseph Torresi, Peter C Richmond, Leon G Heron, et al.
JAMA|April 14, 2011
Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trialOdile Launay, Diane van der Vliet, Arielle R Rosenberg, et al.
Vaccine|August 18, 2015
Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: a randomised studyJoseph Torresi, Leon G Heron, Ming Qiao, et al.
Arthritis Care & Research|April 5, 2013
Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort studySolen Kernéis, Odile Launay, Thierry Ancelle, et al.
Elife|September 6, 2017
Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacyMaia A Rabaa, Yves Girerd-Chambaz, Kien Duong Thi Hue, et al.
Vaccine|January 13, 2009
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trialOdile Launay, Christine Sadorge, Nathalie Jolly, et al.
Pageof 2